Replies to post #195620 on Innovation Pharmaceuticals Inc (IPIX)

[BonelessCat]

No, not necessarily. All 10 could be in the 400mg arm if placebo and 300mg, and 400mg met the 162 (total) and 27 subjects, respectively. The 3:3:1 trial design may have had the possibility of adding patients in mind if the 400mg arm appeared to have stronger numbers based on raw blinded 27 patient results.